Acute Gastroenteritis Clinical Trial
Official title:
Video Discharge Instructions for Pediatric Gastroenteritis in an Emergency Department: a Randomized, Controlled Trial
Video discharge instructions (VDI) have been suggested as a useful strategy to improve discharge instructions in pediatric emergency units. The goal of this study is to evaluate if the addition of VDI to usual verbal information improved the comprehension of information provided to caregivers of patients who consult for acute gastroenteritis (AGE). An open-label, parallel, randomized trial was designed, enrolling patients who consult for AGE. First, caregivers answer a written test concerning AGE characteristics and management. They are randomly allocated to a control group, which receives verbal discharge instructions, or to an intervention group, which additionally receives video discharge instructions. After discharge, caregivers are contacted by telephone and answer the same test. Main outcome measure is difference between test scores in the first and the second tests, secondary endpoints are how many caregivers score 5/5 on the second test, as well as rate of return visits and caregivers satisfaction with the information received.
Video discharge instructions (VDI) have been suggested as a useful strategy to improve
discharge instructions in pediatric emergency units. This study is designed to evaluate if
the addition of VDI to usual verbal information improves the comprehension of the information
provided to caregivers of patients who consult in pediatric emergency department for acute
gastroenteritis (AGE). Secondary objectives are evaluating if video instructions improve
satisfaction with the information received and decrease return visits.
The study is an open-label, parallel, randomized trial which takes place between June 2019
and June 2020 in the pediatric emergency department of a third-level Spanish hospital which
receives 58000 emergencies annually. Up to 3 eligible patients are enrolled every shift when
one of the main investigators is present. Simple, 1:1 randomization is performed using R
software. Patients are randomly assigned to a group by opening sequentially numbered paper
envelopes which contain the group in which the patient will be allocated, ensuring thus
allocation concealment. Written informed consent is provided before trial enrollment.
Interventions
The trial is developed in three steps: an initial written test, an information phase and a
second follow-up test after discharge. After enrollment, all patients fill-in a written test
before discharge, which consists of 5 questions about AGE, 1 point per correct answer.
Enrolled subjects are randomly assigned to the control or intervention group. In the first
group of subjects (control group) caregivers receive, after completing the test and prior to
discharge, the usual verbal information and recommendations about AGE following the
guidelines of the Spanish Society of Pediatric Emergencies. In the second group (intervention
group) patients are shown a short 2-minute video providing the same information about AGE, in
addition to verbal instructions. In both groups, instructions are given by one of the main
investigators in order to provide homogeneous and consistent information. Both sets of
instructions explicitly include the information that had been previously asked in the test.
All patients additionally receive a discharge report which includes instructions concerning
aftercare treatment.
After discharge, all caregivers are contacted by telephone and asked the same 5 questions
from the initial test. The questionnaire has to be completed by the same caregiver as in the
previous test. This test also includes questions about subsequent visits to either emergency
units or outpatient pediatric clinics and satisfaction with the information. The first
telephonic contact is established 72 hours after discharge, and if unable to contact,
repeated every 1-2 days up to a total of 5 days before excluding them and considering them as
lost in follow-up.
Statistical Analysis The sample size was calculated to provide a statistical power of 80% at
an alpha level of 5% to detect a two-tailed difference of 0.5 points between the two groups.
It was calculated that with an estimated loss rate of 15% of patients between randomization
and follow-up test, assuming a 1-point variance in test results based on previous studies,
this statistical power would be reached by enrolling 75 patients in each group.
All randomized patients who complete both tests are included in the primary-end point
analysis as part of the group in which they were randomized, following intention-to-treat
principle. The differences in test points and satisfaction between groups are analyzed using
Student's T-test, and the differences in proportions are analyzed using Chi-square test.
Statistical significance is set at p<0.05. Analysis are performed using Rv3.6.1 and SPSS.25
statistical softwares.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04682860 -
Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide
|
Phase 4 | |
Recruiting |
NCT03851835 -
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
|
Phase 3 | |
Completed |
NCT01577043 -
Efficacy of Racecadotril in Acute Watery Diarrhea in Children
|
Phase 4 | |
Completed |
NCT03234777 -
Evaluating a Knowledge Translation Tool for Parents
|
N/A | |
Not yet recruiting |
NCT02619201 -
Antiemetic Efficacy of Ondansetron Versus Metoclopramide
|
Phase 3 | |
Completed |
NCT02280759 -
Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children.
|
Phase 1 | |
Completed |
NCT06090708 -
Yogurt Probiotic Bacteria on Relieving Young Children Acute Gastroenteritis
|
N/A | |
Recruiting |
NCT05270291 -
Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis
|
||
Completed |
NCT02025452 -
Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis
|
Phase 4 | |
Not yet recruiting |
NCT06038305 -
Prevalence of Anemia and Growth Assessment in Acute Gastroenteritis
|
||
Completed |
NCT02803827 -
Optimizing the Management of Acute Diarrhoeal Disease
|
Phase 3 | |
Completed |
NCT02644200 -
Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis
|
Phase 3 | |
Completed |
NCT02174874 -
Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)
|
N/A | |
Completed |
NCT03539913 -
Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children
|
Phase 4 | |
Recruiting |
NCT06137014 -
Fortified Oral Rehydration Therapy for Pediatric Diarrhea
|
Phase 1/Phase 2 | |
Completed |
NCT04555200 -
Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis
|
||
Unknown status |
NCT02177799 -
Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon
|
N/A | |
Completed |
NCT02169817 -
Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children
|
Phase 4 | |
Completed |
NCT01886755 -
Efficacy of an Oral Rehydration Solution Containing the Probiotic Lactobacillus Reuteri Protectis and Zinc in Infants With Acute Gastroenteritis
|
N/A | |
Completed |
NCT01257672 -
Symptomatic Treatment of Acute Gastroenteritis
|
Phase 3 |